# Exploring the role of the key gene TNFAIP3 between periodontitis and influenza A through bioinformatic analysis and molecular docking

## TL;DR

This study finds that the gene TNFAIP3 is linked to both periodontitis and influenza A, suggesting it could be a target for new treatments.

## Contribution

The study identifies TNFAIP3 as a shared key gene and proposes five potential drugs for combined treatment of periodontitis and influenza A.

## Key findings

- TNFAIP3 was identified as a common key gene in periodontitis and influenza A using machine learning.
- Five drugs were found to have potential for combined treatment of both diseases.
- The study reveals a shared immune mechanism involving TNFAIP3 in both conditions.

## Abstract

Recent studies have hinted at a link between periodontitis (PD) and influenza A (IA). Therefore, this study aims to identify key genes common to both diseases by studying Porphyromonas gingivalis (P.gingivalis) and the H1N1 virus, the main pathogen of PD and IA, evaluating the promise of these genes as biomarkers, and providing future therapeutic strategies for both diseases. Our research employs a wide range of methods, including bioinformatics analysis, drug prediction and molecular docking. Ultimately, machine learning algorithms identified TNFAIP3 as a common key gene for PD and IA, and further identified five drugs: Vemurafenib, Metformin, Dexamethasone, Tretinoin and Imatinib with potential for combined treatment of PD and IA. Our study reveals the shared mechanism and immune profile of TNFAIP3 as a key gene in PD and IA, which lays a theoretical foundation for future targeted therapies based on the shared mechanism of the two diseases.